GlaxoSmithKline ( (GB:GSK) ) has issued an update.
GSK plc has announced its total voting rights and capital as of January 31, 2025. The company has an issued share capital of 4,315,116,636 shares, with 169,171,155 shares held in treasury, resulting in 4,145,945,481 voting rights. This information is crucial for shareholders to determine any changes to their interest in the company, in compliance with the Financial Conduct Authority’s rules.
More about GlaxoSmithKline
GlaxoSmithKline (GSK) is a global healthcare company operating in the pharmaceutical industry. It focuses on developing vaccines, specialty medicines, and consumer healthcare products, playing a significant role in the global health and wellness market.
YTD Price Performance: 4.34%
Average Trading Volume: 7,875,958
Technical Sentiment Consensus Rating: Sell
Current Market Cap: £57.33B
For an in-depth examination of GSK stock, go to TipRanks’ Stock Analysis page.